![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Implanet Receives CE Mark for JAZZ Passer
Implanet Receives CE Mark for JAZZ Passer
October 24, 2017
Implanet received CE Mark clearance for the JAZZ Passer product line.
Used in spinal surgery for adult degenerative bone disorder, the implants work around the body’s anatomical structures.
Implanet received 510(k) marketing clearance for JAZZ Passer in September.
Upcoming Events
-
21Oct